BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

Pneumonia, Aspiration Clinical Trial

Official title:
Prospective, Multi-center, Randomized, Non-blind Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Sulbactam/Ampicillin in the Treatment of Pulmonary Abscess and Aspiration Pneumonia

Status Completed

Clinical Trial Summary

The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration pneumonia.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01045902
Study type	Interventional
Source	Bayer
Contact
Status	Completed
Phase	Phase 3
Start date	February 2001
Completion date	January 2005

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00005776` - Inhaled Nitric Oxide Study for Respiratory Failure in Newborns	Phase 3
Completed	`NCT06154486` - Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study
Withdrawn	`NCT02301845` - Validation of Aspiration Markers	Phase 1
Completed	`NCT01301352` - Feeding Children Nasogastrically Versus Nasojejunally While Receiving Noninvasive Positive Pressure Ventilation	N/A
Recruiting	`NCT05728242` - Point-of-care Gastric Ultrasound for Fracture Surgery
Terminated	`NCT00005773` - Early Inhaled Nitric Oxide for Respiratory Failure in Newborns	Phase 3
Terminated	`NCT00000362` - Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects	Phase 3